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Four hundred specimens were collected from pediatric 
patients hospitalized in Singapore; 21 of these specimens 
tested positive for human metapneumovirus (HMPV), with 
the A2 genotype predominating. A 5% infection rate was 
estimated, suggesting that HMPV is a signiﬁ  cant cause of 
morbidity among the pediatric population of Singapore.  
H
uman metapneumovirus (HMPV) is a new member of 
the family Paramyxoviridae. It was ﬁ  rst identiﬁ  ed in 
children with respiratory diseases in the Netherlands and is 
now recognized as a substantial cause of acute respiratory 
infection in pediatric patients (1). The clinical symptoms 
in children are similar to those observed during respiratory 
syncytial virus (RSV) infections and vary from upper re-
spiratory tract infection (URTI) to bronchiolitis and pneu-
monia. HMPV infections have been detected in young chil-
dren 5 years of age (2) as well as in adults of all age groups 
(3). Sequence analysis of HMPV isolates has identiﬁ  ed 2 
main lineages, A and B; each group is further subdivided 
into 2 more lineages, A1 and A2, and B1 and B2 (4,5). Both 
virus genotypes were reported in various countries in the 
Americas, Europe, and Asia. This study aims to assess the 
importance of HMPV infection among hospitalized pediat-
ric patients in Singapore.
The Study
Kandang Kerbau Women’s and Children’s hospital is 
one of the major centers in Singapore for the admission 
of sick children, including those showing respiratory ill-
ness. After obtaining prior approval from the Hospital’s 
ethics committee (approval number EC/043/2004), we col-
lected nasopharyngeal swabs from 400 pediatric patients 
between October 2005 and January 2007. When admitted 
to the hospital, these patients exhibited symptoms of acute 
lower respiratory tract infections (LRTI) (bronchiolitis, 
bronchitis, pneumonia, asthma, and wheezing) and URTI 
(pharnygitis). Specimens were sent to the hospital’s micro-
biologic laboratory for routine testing for inﬂ  uenza A and 
B viruses, RSV, adenovirus, and parainﬂ  uenza virus (sero-
types 1–3) by immunoﬂ  uorescence assay (LIGHTDIAG-
NOSTICS, Chemicon, Tamacula, CA, USA). The clinical 
specimens were stored at –80oC until further analysis for 
HMPV was performed (not longer than a week after col-
lection). Viral RNA (vRNA) was extracted from each of 
the thawed nasopharyngeal swabs with the QIAamp viral 
RNA minikit (QIAGEN Inc., Valencia, CA, USA) accord-
ing to the manufacturer’s instructions. Of the total RNA 
extracted from the clinical specimens, 5 μL was subjected 
to real-time reverse transcription–PCR (RT-PCR) testing 
by using the N gene speciﬁ  c primer set NL–N (6). This 
was performed with the OneStep RT–PCR kit (QIAGEN) 
on a Corbett Research Rotorgene 3000 (Corbett Life Sci-
ence, Sydney, NSW, Australia). The PCR cycling condi-
tions were 50oC for 30 min, 95oC for 15 min, and 45 cycles 
(95oC for 20 s and 60oC for 60 s). Specimens that tested 
positive by real-time RT-PCR analysis were conﬁ  rmed by 
conventional RT–PCR by using the NL–N primer set. The 
ampliﬁ  ed products (163 bp) were detected by using aga-
rose gel electrophoresis, and their identity was conﬁ  rmed 
by DNA sequencing. 
Of the 400 samples collected, 21 tested positive for 
HMPV infection, which suggests an incidence rate of 
≈5.3%, compared with an 11.5% incidence rate for RSV 
(Table 1). Previous reports have suggested that in some 
cases severe symptoms exhibited by RSV-infected patients 
are associated with dual infections involving HMPV (7). 
Although we detected the presence of HMPV and RSV in 
the patients screened, no evidence for co-infections was 
observed, which suggests a low occurrence for these vi-
ruses in Singapore. In a recent study in Australia, only 8 of 
10,000 screened hospitalized patients showed evidence of 
co-infection with HMPV and RSV (8). In contrast, several 
recent studies suggest that co-infections may account for a 
substantial number of instances in which HMPV has been 
detected. For example, a recent study in Brazil, which used 
a lower sample size than in our study, reported an 8% inci-
dence rate for pediatric patients who had RSV and HMPV 
co-infections (9). Therefore, environmental factors may be 
a key feature in the development of co-infections.
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Table 1. Positive test results for respiratory viruses from clinical 
specimens (n = 400) 
Virus No.  positive  (%) 
Respiratory syncytial virus  46 (11.5) 
Influenza A virus  3 (0.8) 
Influenza B virus  1 (0.3) 
Parainfluenza 1 virus  4 (1.0) 
Parainfluenza 2 virus  0 (0) 
Parainfluenza 3 virus  8 (2.0) 
Adenovirus 1 (0.3)
Human metapneumovirus  21 (5.3) 
Total 84 (21.0) Human Metapneumovirus in Children
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The entire P gene sequences were ampliﬁ  ed directly 
from the specimens by RT–PCR using the primers hmptPF 
5′-ATGTCGTTCCCTGAAGGAAAAGATATTC-3′ and 
hmptPR 5′-TTAAACTACATAATTAAGTGGTAAAT-
3′. Amplicons 884 bp in size were generated and cor-
responded to 1209 nt–2093 nt of the HMPV genome 
(strain JPS03-240, AY530095). PCR cycling was per-
formed on a conventional thermal cycler by using a 
“touch-down” procedure; conditions were 94oC for 5 min 
followed by 30 cycles of 94oC for 15 s, 62oC (reducing 
by 0.5oC/cycle) for 30 s, 72oC for 1 min, and a ﬁ  nal ex-
tension step of 72oC for 7 min. The sizes of the respec-
tive PCR-ampliﬁ   ed products were examined by using 
agarose gel electrophoresis, gel-puriﬁ  ed, and conﬁ  rmed 
by DNA sequencing. The sequences were submitted to 
GenBank under accession nos. EF409351–EF409371. 
The genetic relationship between the Singapore HMPV 
isolates and those HMPV isolates described previ-
ously was analyzed by comparing the P gene sequences 
(10). Alignments of nucleic acid sequences were cre-
ated by using ClustalX version 1.83 (bips.u-strasbg.fr/fr/
documentation/clustalx). Phylogenetic trees were construct-
ed by using the neighbor-joining method (1,000 bootstrap 
replicates) and edited with MEGA 3.1 (11). Comparisons 
were made with representatives of the 4 genetic lineages 
(Figure). This analysis shows that although isolates rep-
resenting both A and B genotypes were detected, the Sin-
gapore isolates clustered more predominantly with rep-
resentative HMPV strains in lineage A, in particular the 
sublineage A2. In this study HMPV was detected through-
out the year, which suggests that in Singapore, HPMV is 
present in the pediatric community throughout the year. 
We also noted a slight increase in the incidence of B gen-
otypes (B1 and B2) during the last quarter of 2006, but the 
implications of this ﬁ  nding are unclear. 
The age and clinical characteristics of the HMPV pa-
tients were next compared with the different HMPV lineag-
es (Table 2). Children with HMPV infection were 1 month 
to 12 years in age; 67% were <1 year of age compared with 
63% of RSV-infected children. Of the HMPV-infected pa-
tients, 52% exhibited LRTI; of these, 82% were infected 
with the HMPV sublineage A2. In contrast, ≈43% of the 
patients exhibited URTI caused by the sublineages A2 and 
B2. In comparison, 61% and 20% of the RSV patients had a 
clinical diagnosis of LRTI or URTI, respectively. Our data 
suggested an increased association of sublineage A2 with 
LRTI in the HMPV-infected patients. The implications of 
this are unclear, but several reports note a correlation be-
tween severity of infection and the presence of the A geno-
type (12,13). Unfortunately, we were not able to make a 
strict comparison of our data with data from recent studies 
in Southeast Asia (14,15); these studies used signiﬁ  cantly 
smaller sample sizes and a different selection criterion for 
Figure. Phylogenetic analyses of nucleotide sequences of 
HMPV phosphoprotein showing comparisons with Singapore-
Nanyang Technological University (SIN06-NTU*) sequences. The 
specimen number acquired during the course of the investigation 
(e.g., SIN06-NTU14) was made with known strains (highlighted 
S) from Canada [CAN99-81 (AY145294, AY145249), CAN97-
83 (AY297749), CAN97-82 (AY145295, AY145250), CAN98-75 
(AY297748), CAN98-79 (AY145293, AY145248)], Japan [JPS03-
180 (AY530092), JPS03-240 (AY530095), JPS03-187 (AY530093), 
JPS02-76 (AY530089)], and the Netherlands [NL-1-00 (AF371337), 
NL-17-00 (AY304360), NL-1-99 (AY525843), NL-1-94 (AY304362)]. 
Avian pneumovirus type C (APVC AY590688) was used as the 
outgroup. DISPATCHES
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the patients screened (i.e., LRTI [14] and wheezing and 
asthma [15]).  
Conclusions
Our study is the ﬁ  rst, to our knowledge, that has at-
tempted to assess the importance of HMPV among the pe-
diatric population in Singapore. We analyzed 400 samples 
that were collected from pediatric patients who were admit-
ted to a hospital over a 16-month period. An infection rate 
of 5.3% was observed, which is consistent with the report-
ed infection rates of several other industrialized countries. 
We also noted that of the viruses detected, ≈67% were of 
the A subtype and 33% were of the B subtype, which sug-
gests that the former was the predominant HMPV subtype 
causing illness in these patients. Furthermore, a signiﬁ  cant 
proportion of the HMPV-infected patients had LRTI. Our 
ﬁ  ndings suggest that HMPV is a substantial cause of illness 
among the pediatric population of Singapore. 
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Table 2. Characteristics of pediatric patients with human 
metapneumovirus (HMPV) infection 
Patient no.  Age
Clinical
diagnosis*
Lineage of 
HMPV
14 2 y L A2
29 1 y O A2
50 6 mo U A2
51 1 y L A2
52 1 y U A2
70 11 mo U A2
84 6 mo U A2
101 1 y L A2
102 2 y L A2
135 1 y U B2
187 3 mo L A2
217 1 mo L B1
224 1 y U B2
232 1 y L A2
271 12 y L A2
272 4 y U B2
273 1 y U B2
277 5 y U B2
289 1 y L A2
384 2 y L A2
398 7 y L B2
*L, lower respiratory infections including bronchiolitis, bronchitis, 
pneumonia, asthma, wheezing or chest infection; U, upper respiratory 
infections including infantile pyrexia and pharyngitis; O, febrile fit. 
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